Trinity Biotech (TRIB) Operating Expenses (2016 - 2024)
Historic Operating Expenses for Trinity Biotech (TRIB) over the last 16 years, with Q4 2024 value amounting to -$9.8 million.
- Trinity Biotech's Operating Expenses fell 2194.64% to -$9.8 million in Q4 2024 from the same period last year, while for Jun 2025 it was -$24.8 million, marking a year-over-year increase of 2475.64%. This contributed to the annual value of -$37.5 million for FY2024, which is 565.14% down from last year.
- Latest data reveals that Trinity Biotech reported Operating Expenses of -$9.8 million as of Q4 2024, which was down 2194.64% from -$7.5 million recorded in Q3 2024.
- Over the past 5 years, Trinity Biotech's Operating Expenses peaked at -$6.2 million during Q2 2020, and registered a low of -$10.8 million during Q4 2022.
- Its 5-year average for Operating Expenses is -$7.9 million, with a median of -$7.5 million in 2020.
- As far as peak fluctuations go, Trinity Biotech's Operating Expenses crashed by 6622.2% in 2022, and later surged by 2568.95% in 2023.
- Trinity Biotech's Operating Expenses (Quarter) stood at -$8.2 million in 2020, then grew by 20.03% to -$6.5 million in 2021, then crashed by 66.22% to -$10.8 million in 2022, then increased by 25.69% to -$8.1 million in 2023, then fell by 21.95% to -$9.8 million in 2024.
- Its Operating Expenses stands at -$9.8 million for Q4 2024, versus -$7.5 million for Q3 2024 and -$7.4 million for Q2 2024.